Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - EPIRUS Biopharmaceuticals, Inc. | Financial_Report.xls |
EX-31.2 - EX-31.2 - EPIRUS Biopharmaceuticals, Inc. | d544526dex312.htm |
EX-31.1 - EX-31.1 - EPIRUS Biopharmaceuticals, Inc. | d544526dex311.htm |
10-Q - FORM 10-Q - EPIRUS Biopharmaceuticals, Inc. | d544526d10q.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as principal executive officer and principal financial officer of Zalicus Inc. (the Company), do hereby certify that to their knowledge:
1) | the Companys Form 10-Q for the fiscal quarter ended June 30, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2) | the information contained in the Companys Form 10-Q for the fiscal quarter ended June 30, 2013 fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ Mark H. N. Corrigan |
Mark H. N. Corrigan President and Chief Executive Officer (principal executive officer) |
/s/ Justin A. Renz |
Justin A. Renz Executive Vice President and Chief Financial Officer (principal financial officer) |
Dated: August 5, 2013